PLK4 and hepatocellular carcinoma: The overexpression of MCM10, KIF18A, CDC45, and PLK4 in the HCC group was confirmed through bioinformatics analysis and RT-qPCR, which could be particularly significant for identifying new therapeutic targets for HCC.